Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Adam H Schechter. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Adam H Schechter har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:DVA / DaVita Inc. | Director | 4 699 |
US:LH / Labcorp Holdings Inc. | President & CEO, Director | 93 319 |
US:MRK / Merck & Co., Inc. | EVP & Pres-Global Human Health | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Adam H Schechter. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Adam H Schechter som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 369 | 4 699 | 8,52 | ||||
2025-08-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −5 643 | 93 319 | −5,70 | 266,78 | −1 505 440 | 24 895 643 |
2025-05-16 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 348 | 4 330 | 8,74 | ||||
2025-05-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −6 105 | 98 962 | −5,81 | 248,73 | −1 518 497 | 24 614 818 |
2025-03-31 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −13 584 | 105 067 | −11,45 | 231,67 | −3 147 005 | 24 340 872 | |
2025-03-31 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
A - Award | 30 469 | 118 651 | 34,55 | ||||
2025-03-18 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 349 | 3 982 | 9,61 | ||||
2025-02-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −1 226 | 88 182 | −1,37 | 245,14 | −300 542 | 21 616 935 | |
2025-02-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
M - Exercise | 2 963 | 89 408 | 3,43 | ||||
2025-02-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −6 121 | 86 445 | −6,61 | 244,62 | −1 497 319 | 21 146 176 |
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −1 345 | 92 566 | −1,43 | 246,27 | −331 233 | 22 796 229 | |
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
M - Exercise | 3 250 | 93 911 | 3,58 | ||||
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −1 240 | 90 661 | −1,35 | 247,74 | −307 198 | 22 460 356 | |
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
M - Exercise | 4 460 | 91 901 | 5,10 | ||||
2024-11-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 312 | 3 633 | 9,39 | ||||
2024-11-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −6 189 | 87 441 | −6,61 | 243,47 | −1 506 836 | 21 289 260 |
2024-08-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 333 | 3 321 | 11,14 | ||||
2024-05-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 363 | 2 988 | 13,83 | ||||
2024-03-29 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −31 799 | 93 630 | −25,35 | 216,57 | −6 886 709 | 20 277 449 | |
2024-03-29 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 72 435 | 125 429 | 136,69 | ||||
2024-03-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 366 | 2 625 | 16,20 | ||||
2024-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 231 | 52 994 | −2,27 | 227,45 | −279 991 | 12 053 485 | |
2024-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 964 | 54 225 | 5,78 | ||||
2024-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 149 | 51 261 | −2,19 | 223,71 | −257 043 | 11 467 598 | |
2024-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 250 | 52 410 | 6,61 | ||||
2024-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −822 | 49 160 | −1,64 | 221,54 | −182 106 | 10 890 906 | |
2024-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 094 | 49 982 | 6,60 | ||||
2023-11-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 529 | 2 259 | 30,58 | ||||
2023-08-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 475 | 1 730 | 37,85 | ||||
2023-05-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 516 | 1 255 | 69,82 | ||||
2023-04-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −18 646 | 46 888 | −28,45 | 224,70 | −4 189 756 | 10 535 734 | |
2023-04-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
A - Award | 42 353 | 65 534 | 182,71 | ||||
2023-03-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 658 | 739 | 812,35 | ||||
2023-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 170 | 23 181 | −4,80 | 248,13 | −290 312 | 5 751 902 | |
2023-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 656 | 24 351 | 12,24 | ||||
2023-02-07 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 368 | 21 695 | −5,93 | 244,50 | −334 476 | 5 304 428 | |
2023-02-07 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 507 | 23 063 | 17,93 | ||||
2023-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −805 | 19 556 | −3,95 | 254,99 | −205 267 | 4 986 584 | |
2023-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 773 | 20 361 | 15,77 | ||||
2022-11-16 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 81 | 81 | |||||
2022-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −893 | 17 588 | −4,83 | 222,56 | −198 746 | 3 914 385 | |
2022-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 007 | 18 481 | 12,18 | ||||
2022-09-29 | 3 | DVA |
DAVITA INC.
No securities are beneficially owned |
0 | ||||||||
2022-02-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 28 100 | 28 100 | |||||
2022-02-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 7 970 | 19 031 | 72,05 | ||||
2022-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −3 507 | 11 061 | −24,07 | ||||
2022-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 412 | 16 474 | −7,89 | 277,48 | −391 802 | 4 571 206 | |
2022-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 507 | 17 886 | 24,39 | ||||
2022-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −2 773 | 14 568 | −15,99 | ||||
2022-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −803 | 14 379 | −5,29 | 273,18 | −219 364 | 3 928 055 | |
2022-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 773 | 15 182 | 22,35 | ||||
2021-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −2 007 | 17 341 | −10,37 | ||||
2021-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −886 | 12 409 | −6,66 | 288,78 | −255 859 | 3 583 471 | |
2021-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 007 | 13 295 | 17,78 | ||||
2021-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −3 506 | 19 348 | −15,34 | ||||
2021-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 028 | 11 288 | −8,35 | 223,78 | −230 046 | 2 526 029 | |
2021-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 506 | 12 316 | 39,80 | ||||
2021-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 29 000 | 29 000 | |||||
2021-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 8 320 | 22 854 | 57,25 | ||||
2020-11-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −2 006 | 14 534 | −12,13 | ||||
2020-11-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −885 | 8 810 | −9,13 | 207,23 | −183 399 | 1 825 696 | |
2020-11-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 006 | 9 695 | 26,09 | ||||
2020-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 227 | 16 540 | −6,91 | ||||
2020-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 227 | 7 689 | 18,99 | ||||
2020-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 45 600 | 45 600 | |||||
2020-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 10 520 | 17 767 | 145,16 | ||||
2019-11-05 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 65 100 | 65 100 | |||||
2019-11-05 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 24 800 | 24 800 | |||||
2019-11-05 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 6 020 | 7 247 | 490,63 | ||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 227 | 1 227 | |||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 038 | 0 | −100,00 | ||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 038 | 6 462 | 19,14 | ||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
G - Gift | −610 | 5 424 | −10,11 | ||||
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −277 879 | 0 | −100,00 | ||||
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −145 135 | 0 | −100,00 | 73,66 | −10 691 181 | |
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −132 744 | 145 135 | −47,77 | 73,98 | −9 819 764 | 10 736 391 |
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 277 879 | 277 879 | 39,29 | 10 917 866 | 10 917 866 | ||
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −100 000 | 0 | −100,00 | ||||
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −7 360 | 55 406 | −11,73 | 70,18 | −516 511 | 3 888 286 |
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −100 000 | 0 | −100,00 | 70,18 | −7 017 780 | |
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 100 000 | 100 000 | 36,56 | 3 656 000 | 3 656 000 | ||
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −100 000 | 100 000 | −50,00 | ||||
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −34 094 | 62 766 | −35,20 | 61,00 | −2 079 785 | 3 828 819 |
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −100 000 | 0 | −100,00 | 61,00 | −6 100 160 | |
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 100 000 | 100 000 | 36,56 | 3 656 000 | 3 656 000 | ||
2018-05-08 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 139 063 | 139 063 | |||||
2018-03-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 34 094 | 34 094 | 54,72 | 1 865 624 | 1 865 624 | ||
2018-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 038 | 1 038 | |||||
2018-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
S - Sale | X | −1 263 | 6 034 | −17,31 | 169,29 | −213 813 | 1 021 496 |
2018-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 263 | 0 | −100,00 | ||||
2018-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 263 | 7 297 | 20,93 | ||||
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −50 994 | 200 000 | −20,32 | ||||
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −50 608 | 62 766 | −44,64 | 61,63 | −3 118 971 | 3 868 267 |
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −50 994 | 0 | −100,00 | 61,63 | −3 142 760 | |
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 50 994 | 50 994 | 36,56 | 1 864 341 | 1 864 341 | ||
2017-12-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
G - Gift | −750 | 113 374 | −0,66 | ||||
2017-05-09 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 162 625 | 162 625 | |||||
2017-04-10 |
|
4/A | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 37 758 | 37 758 | 65,85 | 2 486 364 | 2 486 364 | ||
2017-04-04 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −53 850 | 116 336 | −31,64 | 63,48 | −3 418 166 | 7 384 507 |
2017-03-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 39 970 | 39 970 | 65,85 | 2 632 024 | 2 632 024 | ||
2017-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 560 | 1 263 | −55,26 | ||||
2017-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 560 | 6 034 | 34,87 | ||||
2017-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 263 | 2 823 | 80,96 | ||||
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −26 135 | 0 | −100,00 | ||||
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −10 200 | 250 994 | −3,91 | ||||
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −36 335 | 0 | −100,00 | 63,73 | −2 315 699 | |
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 10 200 | 36 335 | 39,03 | 36,56 | 372 912 | 1 328 408 | |
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 26 135 | 26 135 | 33,49 | 875 261 | 875 261 | ||
2016-09-01 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −39 200 | 26 135 | −60,00 | ||||
2016-09-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −39 200 | 0 | −100,00 | 62,61 | −2 454 308 | |
2016-09-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 39 200 | 39 200 | 33,49 | 1 312 808 | 1 312 808 | ||
2016-07-01 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2016-07-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −50 000 | 0 | −100,00 | 57,69 | −2 884 415 | |
2016-07-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 50 000 | 50 000 | 44,30 | 2 215 000 | 2 215 000 | ||
2016-05-12 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 258 065 | 258 065 | |||||
2016-03-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 237 | 1 560 | −44,23 | ||||
2016-03-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 237 | 4 474 | 38,21 | ||||
2016-02-24 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 37 223 | 37 223 | 50,77 | 1 889 812 | 1 889 812 | ||
2016-02-11 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 560 | 2 797 | 126,11 | ||||
2015-05-11 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | −10 634 | 0 | −100,00 | 60,44 | −642 768 | ||
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Restricted Stock Unit |
M - Exercise | −19 343 | 0 | −100,00 | 59,86 | −1 157 872 | ||
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
F - Taxes | −8 709 | 10 634 | −45,02 | 59,86 | −521 321 | 636 551 | |
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 19 343 | 19 343 | |||||
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 235 294 | 235 294 | |||||
2015-03-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 237 | 1 237 | |||||
2015-02-25 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 22 198 | 22 198 | 58,30 | 1 294 143 | 1 294 143 | ||
2015-02-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 503 | 0 | −100,00 | ||||
2015-02-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 503 | 3 237 | 86,68 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −19 200 | 0 | −100,00 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −74 200 | 0 | −100,00 | 62,48 | −4 636 224 | |
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 5 000 | 74 200 | 7,23 | 34,47 | 172 350 | 2 557 674 | |
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 19 200 | 69 200 | 38,40 | 35,09 | 673 728 | 2 428 228 | |
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 50 000 | 50 000 | 44,19 | 2 209 500 | 2 209 500 | ||
2014-11-25 |
|
4 | MRK |
Merck & Co. Inc.
Phantom Stock |
S - Sale | −2 779 | 0 | −100,00 | ||||
2014-08-25 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | X | −22 000 | 70 795 | −23,71 | 59,70 | −1 313 380 | 4 226 396 |
2014-05-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 503 | 1 503 | |||||
2014-05-14 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | X | −10 527 | 0 | −100,00 | 55,91 | −588 584 | |
2014-05-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
A - Award | 209 078 | 209 078 | |||||
2014-05-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 593 | 0 | −100,00 | ||||
2014-05-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 593 | 1 734 | 1 129,79 | 98,96 | 157 643 | 171 597 | |
2014-05-06 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −19 147 | 0 | −100,00 | 58,22 | −1 114 738 | ||
2014-05-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −8 620 | 10 527 | −45,02 | 58,22 | −501 856 | 612 882 | |
2014-05-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 19 147 | 19 147 | |||||
2014-02-26 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
A - Award | 22 287 | 22 287 | 56,18 | 1 252 084 | 1 252 084 | ||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −3 000 | 0 | −100,00 | ||||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −12 500 | 0 | −100,00 | ||||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock - 401(k) Plan |
I - Other | −4 040 | 0 | −100,00 | 55,70 | −225 049 | ||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | −18 000 | 0 | −100,00 | 55,61 | −1 000 935 | ||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 2 500 | 18 000 | 16,13 | 47,39 | 118 475 | 853 020 | |
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 3 000 | 15 500 | 24,00 | 45,41 | 136 230 | 703 855 | |
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 12 500 | 12 500 | 48,24 | 603 000 | 603 000 | ||
2013-05-16 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 593 | 1 593 | |||||
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −12 188 | 0 | −100,00 | 44,98 | −548 216 | ||
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −5 488 | 22 416 | −19,67 | 44,98 | −246 850 | 1 008 252 | |
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 12 188 | 27 904 | 77,55 | ||||
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
A - Award | 244 767 | 244 767 | |||||
2013-04-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
A - Award | 141 | 141 | |||||
2013-02-27 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
A - Award | 8 136 | 15 568 | 109,47 | 42,52 | 345 943 | 661 951 | |
2013-02-20 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −10 670 | 0 | −100,00 | 41,42 | −441 951 | ||
2013-02-20 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −3 238 | 7 432 | −30,35 | 41,42 | −134 118 | 307 833 | |
2013-02-20 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 10 670 | 10 670 | |||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −61 200 | 0 | −100,00 | ||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | −56 300 | 14 900 | −79,07 | 45,60 | −2 567 257 | 679 434 | |
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 5 000 | 71 200 | 7,55 | 28,42 | 142 100 | 2 023 504 | |
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 5 000 | 66 200 | 8,17 | 31,84 | 159 200 | 2 107 808 | |
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 61 200 | 61 200 | 23,45 | 1 435 140 | 1 435 140 | ||
2012-05-04 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
A - Award | 277 879 | 277 879 | |||||
2012-05-04 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
A - Award | 19 343 | 19 343 | |||||
2012-04-26 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −11 475 | 0 | −100,00 | 38,27 | −439 148 | ||
2012-04-26 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −4 535 | 7 035 | −39,20 | 38,27 | −173 554 | 269 226 | |
2012-04-26 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 11 475 | 11 570 | 12 089,51 | ||||
2012-03-01 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
A - Award | 9 194 | 9 194 | 38,38 | 352 866 | 352 866 | ||
2010-05-06 | 3 | MRK |
Merck & Co. Inc.
Common Stock - 401(k) Plan |
9 804 |